GSK supporting Vietnamese healthcare for 25 years

GSK supporting Vietnamese healthcare for 25 years

How do you see GSK’s role and mission to improve quality for Vietnamese people over the past 25 years?

We are honoured to be part of Vietnam’s healthcare sector and to have contributed to the industry’s development in the past 25 years. We are proud to be a trusted partner of the Vietnamese Ministry of Health, embassies, non-governmental organisations (NGOs), medical associations, healthcare professionals, and strategic partners, working together towards the ultimate goal of providing comprehensive healthcare from prevention to treatment.

Accordingly, GSK has been investing intensively in new global R&D approaches focused on the immune system, genetic use, and advanced technologies such as artificial intelligence, to accelerate the process of medicine discovery. In addition, we promote sustainable business growth through a diverse product pipeline to ensure patients can access our medications and vaccines whenever they need them.

On this special occasion, we would like to extended our heartfelt thanks to the MoH, embassies, NGOs, medical associations, the University of Medicine and Pharmacy, doctors and pharmacists nationwide, and our partners for being trustworthy companions on our journey to bring a better life to Vietnamese people, helping them to do more, feel better and live longer.

Which factors should a science-based healthcare multinational corporation focus on to reinforce its value in the local community?

Building trust matters the most. At GSK, values always lead all activities and decisions where patients are focused, respecting people, transparency, and integrity. We build trust based on scientific research and by developing quality medicines and vaccines for everyone, as well as ensuring a reliable supply of medicines and vaccines with strong commitment to quality and safety. It’s the way we work with our partners that shows our responsibility in addressing global health challenges and improving access to medicines and vaccines that demonstrate our values in every country where we operate.

Globally, GSK and Save the Children have launched a five-year partnership to the most vulnerable children of the world In Vietnam, GSK and Save the Children have implemented a healthcare project for mothers and newborns of ethnic minorities in region, which aimed at training health workers, improving newborn care units, and establishing Kangaroo Mother Care Units at the localities to improve access to mother and newborn healthcare services at grass-roots level medical stations. The project also focused on educating and raising public awareness on mother and newborn healthcare, thus boosting the for local healthcare services and increasing access to basic .

Other major projects of GSK include the Healthcare Innovation Award worth $400,000 given to PATH Vietnam for its digital immunisation registry system that supports the Ministry of Health’s National Immunisation Management System deployment; offering preventive healthcare to GSK’s employees and their family as we believe our mission starts from the inside by taking care of employees and their families’ health and well-being; and organising volunteer programmes that enable GSK’s employees to utilise their expertise in social activities that benefit the community, and to come up with initiatives that help the vulnerable access fundamental healthcare services.

In the era of Industry 4.0, the healthcare industry should evolve and adapt to catch new healthcare trends and meet public expectations. What are GSK’s directions for Vietnam’s market in the upcoming time?

In Vietnam, we pledge to continue offering innovative solutions that work on Vietnam’s disease pattern, meeting the needs of both health professionals and patients. We aim to continuously stay a trusted partner in providing innovative healthcare solutions to solve healthcare challenges such as using the appropriate antibiotics to tackle Antimicrobial resistance, managing non-communicable diseases like asthma/Chronic Obstructive Pulmonary Disease, enhancing public awareness on the burden of infectious diseases, as well as increasing immunisation coverage to create a healthy community for Vietnam.

We also aim to become the leading company in healthcare digital communication by modenising communication via various channels like email, website portals, and webinars to enhance continuous e-learning and provide quick access to the most up-to-date treatment and medical information in Industry 4.0. Particularly, we have successfully organised a multidimensional medical forum on comprehensive respiratory care from prevention to treatment in early June, which was webcast in more than 20 provinces and cities nationwide and reached more than 2,800 healthcare practitioners.

In addition, GSK’s top priority is to provide sufficient, quality vaccine and pharmaceuticals for Vietnam in full compliance with GSK’s highest standards. Vietnam is among the countries where respiratory ailments have not been well controlled or treated; therefore, we prioritise introducing innovative medicines for the treatment of such diseases. Another priority is to introduce new vaccines that protect children from dangerous communicable diseases in future.

To deliver our mission of helping people to do more, feel better, and live longer, we value our people as the most important asset of GSK. We aim to become a modern employer and create a positive workplace where everyone can be at their best, bringing their own expertise and strength to contribute to GSK’s development, where everyone can feel good to work for GSK, and where everyone keeps growing as an individual.

In the future, we hope that no children would die from dangerous preventable infections, no patients would have to struggle to breathe, and antibiotics will still be conserved as a priceless asset that helps us defeat bacterial infections.